EXAS
Exact Sciences Corporation
$47.42
+$0.47(+1.00%)
30
Overall
--
Value
30
Tech
--
Quality
Market Cap
$8.73B
Volume
3.32M
52W Range
$38.81 - $72.83
Target Price
$64.50
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $39.4M | $99.4M | $266.0M | $454.5M | $876.3M | $1.5B | $1.8B | $2.1B | $2.5B | $2.8B | ||
| Total Revenue | $39.4M | $99.4M | $266.0M | $454.5M | $876.3M | $1.5B | $1.8B | $2.1B | $2.5B | $2.8B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $24.5M | $-45.2M | $-78.3M | $-116.6M | $-216.7M | $-354.3M | $458.8M | $574.4M | $737.6M | $840.1M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $14.9M | $54.2M | $187.7M | $337.8M | $659.6M | $1.1B | $1.3B | $1.5B | $1.8B | $1.9B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-174.0M | $-223.2M | $-306.0M | $497.3M | $-893.4M | $-1.7B | $2.1B | $2.1B | $2.1B | $3.0B | ||
| Research & Development | $33.9M | $33.5M | $-42.1M | $67.3M | $139.7M | $-554.1M | $385.6M | $393.4M | $426.9M | $431.2M | ||
| Research Expense | -- | -- | -- | -- | -- | -- | $385.6M | $393.4M | $426.9M | $431.2M | ||
| Selling, General & Administrative | $-136.0M | $-189.7M | $-262.9M | $427.5M | $-737.7M | $1.1B | $1.7B | $1.6B | $1.6B | $1.7B | ||
| Selling & Marketing Expenses | $-30.0M | $-51.3M | $153.9M | $249.4M | $-385.2M | $589.9M | $861.9M | $846.0M | $827.8M | $894.1M | ||
| General & Administrative Expenses | $-106.0M | $-138.4M | $-109.0M | $178.0M | $-352.5M | $481.4M | $801.3M | $737.3M | $800.3M | $781.8M | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | -- | $144.0M | -- | -- | -- | ||
| Salaries & Wages | $-80.4M | $-107.9M | $-137.9M | $-220.2M | $-200.3M | $-298.0M | $253.1M | -- | -- | -- | ||
| Depreciation & Amortization | $-4.1M | -- | $-983.0K | $2.5M | $16.0M | $93.4M | $95.0M | $97.5M | $92.2M | -- | ||
| Depreciation & Amortization | $-4.1M | -- | $-983.0K | $2.5M | $16.0M | $93.4M | $95.0M | $97.5M | $92.2M | -- | ||
| Amortization | -- | -- | $-983.0K | $2.5M | $16.0M | $93.4M | $95.0M | $97.5M | $2.4B | $2.4B | ||
| Other Operating Expenses | -- | -- | -- | -- | -- | $23.7M | $-5.4M | $13.2M | $-78.4M | $-9.2M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-159.1M | $-169.0M | $-118.3M | $-159.5M | $-233.8M | $-558.0M | $-855.7M | $-593.5M | $-215.0M | $-1.0B | ||
| EBITDA | $-149.3M | $-110.8M | $-100.4M | $-89.0M | $97.5M | $-653.9M | $-649.3M | $-421.1M | $24.3M | $-794.3M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $6.0K | $213.0K | $206.0K | $-34.5M | $-48.4M | $-11.8M | $12.9M | $13.9M | $19.4M | $27.0M | ||
| Intinc | -- | -- | -- | -- | -- | -- | $31.8M | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-6.0K | $-213.0K | $-206.0K | $-36.8M | $-51.0M | $-17.1M | $-18.6M | $-19.6M | $-13.2M | $-22.3M | ||
| Gain on Sale of Securities | $1.3M | $2.0M | $3.9M | $21.2M | $26.5M | $6.6M | -- | -- | -- | -- | ||
| Other Income/Expense | $-1.3M | $-2.0M | $-3.9M | $-21.2M | $-16.0M | $253.9M | $-11.6M | $-35.4M | $-2.5B | $856.9M | ||
| Other Special Charges | $6.0M | $6.9M | $44.0K | $68.5M | $200.0K | $200.0K | $31.8M | -- | -- | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | -- | -- | -- | $-10.6M | $-260.5M | -- | $-675.1M | $-621.0K | $-869.5M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $-209.7M | -- | -- | $621.0K | $869.5M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-157.8M | $-121.8M | $-114.4M | $-138.3M | $9.5M | $-817.2M | $-829.6M | $-618.7M | $-182.3M | $-1.0B | ||
| Pre-Tax Income | $-157.8M | $-167.2M | $-114.6M | $-175.1M | $-268.9M | $-829.1M | $-842.5M | $-632.6M | $-201.7M | $-1.0B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | -- | -- | $-187.0K | $-92.0K | $-184.9M | $-5.5M | $-246.9M | $-9.1M | $2.4M | $-7.3M | ||
| NET INCOME | ||||||||||||
| Net Income | $-157.8M | $-167.2M | $-114.4M | $-175.1M | $-84.0M | $-823.6M | $-595.6M | $-623.5M | $-204.1M | $-1.0B | ||
| Net Income (Continuing Operations) | $-157.8M | $-167.2M | $-114.4M | $-175.1M | $-84.0M | $-823.6M | $-595.6M | $-623.5M | $-204.1M | $-1.0B | ||
| Net Income (Discontinued Operations) | $-157.8M | $-167.2M | $-114.4M | $-175.1M | $-84.0M | $-823.6M | $-595.6M | $-623.5M | $-204.1M | $-1.0B | ||
| Net Income (Common Stockholders) | $-157.8M | $-167.2M | $-114.4M | $-175.1M | $-84.0M | $-823.6M | $-595.6M | $-623.5M | $-204.1M | $-1.0B | ||
| Normalized Income | $-102.6M | $-108.7M | $-114.8M | $-199.6M | $-464.3M | $-1.1B | -- | -- | -- | $-174.0M | ||
| TOTALS | ||||||||||||
| Total Expenses | $198.5M | $268.4M | $384.3M | $613.9M | $1.1B | $2.4B | $2.6B | $2.7B | $2.8B | $3.8B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $92.1M | $102.3M | $115.7M | $122.2M | $131.3M | $151.1M | $171.3M | $176.4M | $180.1M | $184.2M | ||
| Average Shares Outstanding (Diluted) | $92.1M | $102.3M | $115.7M | $122.5M | $131.3M | -- | $171.3M | $176.4M | $180.1M | $184.2M | ||
| Shares Outstanding | $97.4M | $110.6M | $120.9M | $125.8M | $148.0M | $169.1M | $174.1M | $178.2M | $181.5M | $185.8M | ||
| Basic EPS | $-1.71 | $-1.63 | $-0.99 | -- | $-0.64 | $-5.61 | $-3.48 | $-3.54 | $-1.13 | $-5.59 | ||
| Basic EPS (Continuing Operations) | $-1.71 | $-1.63 | $-0.99 | $-1.43 | $-0.64 | $-5.61 | $-3.48 | $-3.54 | $-1.13 | $-5.59 | ||
| Diluted EPS | $-1.71 | $-1.63 | $-0.99 | $-1.43 | $-0.64 | $-5.61 | $-3.48 | $-3.54 | $-1.13 | $-5.59 | ||
| Diluted EPS (Continuing Operations) | $-1.71 | $-1.63 | $-0.99 | $-1.43 | $-0.64 | $-5.61 | $-3.48 | $-3.54 | $-1.13 | $-5.59 | ||
| OTHER METRICS | ||||||||||||
| Other Gand A | $-106.0M | $-138.4M | $-109.0M | $178.0M | $-352.5M | $481.4M | $801.3M | $737.3M | $800.3M | $781.8M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | $20.2M | $16.0M | $621.0K | -- | ||
| Othspecchg | -- | -- | -- | -- | $-10.6M | $-50.8M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EXAS | $47.42 | +1.0% | 3.32M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Exact Sciences Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW